Sunday, December 31, 2017

A New Gene Therapy Vision

Vertebrates see by converting photons into electrical signals in the retina, which, in turn are interpreted by the brain into visual depictions of the environment.  Part of this phototransduction system relies on an enzyme called retinoid isomerohydrolase (or retinal pigment epithelium-specific 65 kDa protein ("RPE65")) to convert all-trans-retinyl esters into 11-cis-retinol in the smooth endoplasmic reticulum.  Healthy functioning of retinal pigment epithelium ("RPE"), a thin layer of cells that nurtures the retina, can become impaired when both RPE65 genes contain mutations that prevent normal enzymatic function.  In patients with Confirmed Biallelic RPE65 Mutation-associated Retinal Dystrophy, this can lead to poor vision or even blindness.

The Food and Drug Adminstration ("FDA") announced, on December 19, 2017, its approval of a gene therapy method developed to improve, or even restore, healthy RPE65 enzyme function by introducing wild-type copies of RPE65 genes directly into RPE tissue.  The method involves surgical delivery of RPE65 genes incorporated into adeno-associated viruses.  Spark Therapeutics, the company marketing this gene therapy, calls its "drug" voretigene neparvovec-rzyl (brand-named LUXTURNA).

As the FDA announced, LUXTURNA "is the first directly administered gene therapy approved in the U.S. that targets a disease caused by mutations in a specific gene."  In the FDA press release, FDA Commissioner, Scott Gottlieb, waxed enthusiastic, suggesting that
this milestone reinforces the potential of this breakthrough approach in treating a wide-range of challenging diseases. The culmination of decades of research has resulted in three gene therapy approvals this year for patients with serious and rare diseases. I believe gene therapy will become a mainstay in treating, and maybe curing, many of our most devastating and intractable illnesses[.]
After previous fatal missteps (e.g., see here), gene therapy is finally seeing the light of day.

12 comments:

  1. Yes, my friend, I think I'm a good story for me and many others.



    m8bet

    m8bet

    บาคาร่า

    ReplyDelete
  2. Such useful information! Thank you! My colleague advised using typicalstudent for the same type of content.

    ReplyDelete

  3. For those who want to study. The vertebrates are seen by converting photons into electrical signals in the iris, which can be read on the web.

    บาคาร่า

    ReplyDelete
  4. Test we going to do does not involve penalties. Ray Ban Glasses This is not a penalty Coach Outlet thing, McKay said. Game Ray Ban Outlet administration. Obviously, if Cain and his descendants were the only population in the 'land of Nod' this wouldn't have been much of a city, especially considering the city was built around Yeezy Discount the time his son was born. More of a homestead for just two, maybe three, generations worth of family. Other possible translations for the Hebrew word translated here as 'city' are 'town', 'township', or 'burg', none of which really apply to a place where a rather small family dwells.

    "We know, moreover, a lot about how to do it. The challenge Coach Handbags Clearance is to set this capability free."The virus crisis Coach Outlet Store is liberating many Africans to demand greater resilience in their societies. There is New Jordan Shoes 2020 no shortage of ideas from civil society and financial institutions about how to build a stronger post pandemic economy."As Africans, we are used to being adaptive and innovative, often driven by necessity, and we do have an indefatigable capacity to stand on our own Yeezy Boost 350 feet," writes Alain Tschudin, executive director of Good Governance Africa.With the coronavirus exposing weak governance in Africa, its people are also tapping their strength to fix it.

    ReplyDelete